88 related articles for article (PubMed ID: 3539520)
1. Urinary nucleosides in leukemia: laboratory and clinical applications.
Trewyn RW; Grever MR
Crit Rev Clin Lab Sci; 1986; 24(1):71-93. PubMed ID: 3539520
[TBL] [Abstract][Full Text] [Related]
2. Urinary excretion of modified nucleosides in chronic myelogenous leukemia.
Heldman DA; Grever MR; Speicher CE; Trewyn RW
J Lab Clin Med; 1983 May; 101(5):783-92. PubMed ID: 6572681
[TBL] [Abstract][Full Text] [Related]
3. Relationship of urinary excretion of modified nucleosides to disease status in childhood acute lymphoblastic leukemia.
Heldman DA; Grever MR; Miser JS; Trewyn RW
J Natl Cancer Inst; 1983 Aug; 71(2):269-73. PubMed ID: 6576186
[TBL] [Abstract][Full Text] [Related]
4. [Application of urinary nucleosides in the diagnosis and surgical monitoring of colorectal cancer].
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Yu BM
Zhonghua Wai Ke Za Zhi; 2005 May; 43(9):564-8. PubMed ID: 15938925
[TBL] [Abstract][Full Text] [Related]
5. Age-dependence of urinary normal and modified nucleosides in childhood as determined by reversed-phase high-performance liquid chromatography.
Liebich HM; Müller-Hagedorn S; Bacher M; Scheel-Walter HG; Lu X; Frickenschmidt A; Kammerer B; Kim KR; Gérard H
J Chromatogr B Analyt Technol Biomed Life Sci; 2005 Jan; 814(2):275-83. PubMed ID: 15639449
[TBL] [Abstract][Full Text] [Related]
6. Analysis of urinary nucleosides as potential tumor markers in human colorectal cancer by high performance liquid chromatography/electrospray ionization tandem mass spectrometry.
Hsu WY; Chen WT; Lin WD; Tsai FJ; Tsai Y; Lin CT; Lo WY; Jeng LB; Lai CC
Clin Chim Acta; 2009 Apr; 402(1-2):31-7. PubMed ID: 19135043
[TBL] [Abstract][Full Text] [Related]
7. Differential excretion of modified nucleosides in adult acute leukemia.
Heldman DA; Grever MR; Trewyn RW
Blood; 1983 Feb; 61(2):291-6. PubMed ID: 6571786
[TBL] [Abstract][Full Text] [Related]
8. Study of urinary nucleosides as biological marker in cancer patients analyzed by micellar electrokinetic capillary chromatography.
Zheng YF; Xu GW; Liu DY; Xiong JH; Zhang PD; Zhang C; Yang Q; Lv S
Electrophoresis; 2002 Dec; 23(24):4104-9. PubMed ID: 12481266
[TBL] [Abstract][Full Text] [Related]
9. Normal and modified urinary nucleosides represent novel biomarkers for colorectal cancer diagnosis and surgery monitoring.
Feng B; Zheng MH; Zheng YF; Lu AG; Li JW; Wang ML; Ma JJ; Xu GW; Liu BY; Zhu ZG
J Gastroenterol Hepatol; 2005 Dec; 20(12):1913-9. PubMed ID: 16336453
[TBL] [Abstract][Full Text] [Related]
10. Excretion pattern investigation of urinary normal and modified nucleosides of breast cancer patients by RP-HPLC and factor analysis method.
Xu G; Schmid HR; Lu X; Liebich HM; Lu P
Biomed Chromatogr; 2000 Nov; 14(7):459-63. PubMed ID: 11113924
[TBL] [Abstract][Full Text] [Related]
11. Clinical significance and prognostic value of urinary nucleosides in breast cancer patients.
Zheng YF; Kong HW; Xiong JH; Lv S; Xu GW
Clin Biochem; 2005 Jan; 38(1):24-30. PubMed ID: 15607313
[TBL] [Abstract][Full Text] [Related]
12. Urinary modified nucleosides as tumor markers.
Dudley E; Lemiere F; Van Dongen W; Esmans E; El-Sharkawi AM; Games DE; Brenton AG; Newton RP
Nucleosides Nucleotides Nucleic Acids; 2003; 22(5-8):987-9. PubMed ID: 14565327
[TBL] [Abstract][Full Text] [Related]
13. Analysis of urinary nucleosides. II. Comparison of mass spectrometric methods for the analysis of urinary nucleosides.
Dudley E; Lemiere F; Van Dongen W; Langridge JI; El-Sharkawi S; Games DE; Esmans EL; Newton RP
Rapid Commun Mass Spectrom; 2001; 15(18):1701-7. PubMed ID: 11555869
[TBL] [Abstract][Full Text] [Related]
14. Changes of serum thymidine kinase in children with acute leukemia.
Votava T; Topolcan O; Holubec L; Cerna Z; Sasek L; Finek J; Kormunda S
Anticancer Res; 2007; 27(4A):1925-8. PubMed ID: 17649797
[TBL] [Abstract][Full Text] [Related]
15. [Excretion of beta-aminoisobutyric acid in health, in systemic lupus erythematosus and leukemia].
Mazurik VK; Kondrat'eva AP; Bryskina LE; Nasonova VA
Vopr Med Khim; 1969; 15(1):70-5. PubMed ID: 5258856
[No Abstract] [Full Text] [Related]
16. [Urinary elimination of beta aminoisobutyric acid in malignant hemopathies].
Roulaud F; Boisseau M; Moreau F; Labatut M
C R Seances Soc Biol Fil; 1971; 165(1):83-7. PubMed ID: 4257756
[No Abstract] [Full Text] [Related]
17. DNA methylation of tumor suppressor genes in clinical remission predicts the relapse risk in acute myeloid leukemia.
Agrawal S; Unterberg M; Koschmieder S; zur Stadt U; Brunnberg U; Verbeek W; Büchner T; Berdel WE; Serve H; Müller-Tidow C
Cancer Res; 2007 Feb; 67(3):1370-7. PubMed ID: 17283175
[TBL] [Abstract][Full Text] [Related]
18. Bone marrow transplantation in leukemia.
Gale RP
Ann Clin Res; 1981; 13(4-5):367-72. PubMed ID: 7039488
[TBL] [Abstract][Full Text] [Related]
19. Modified nucleosides in patients with acquired immune deficiency syndrome (AIDS) and individuals at high risk of AIDS: correlations with lymphadenomegaly and immunological parameters.
Fischbein A; Bekesi JG; Solomon S; Borek E; Sharma OK
Cancer Detect Prev Suppl; 1987; 1():589-96. PubMed ID: 3500786
[TBL] [Abstract][Full Text] [Related]
20. Urinary amino acid excretion in subjects with leukaemia.
Lee MB; Neill DW; Bridges JM
J Clin Pathol; 1967 Jan; 20(1):70-4. PubMed ID: 5225727
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
